Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients

A 2024 Louisiana law reclassified misoprostol, a drug used to treat postpartum hemorrhages and in medical abortions, as a controlled substance, requiring hospitals to store it securely instead of in emergency carts. This change delays access to the drug during emergencies, increasing risks for patients with conditions like asthma or high blood pressure who rely on misoprostol as their primary hemorrhage treatment option.